ORIC
ORIC Pharmaceuticals, Inc.
Set alert
9.24 USD +0.25 +2.78%
8.28 Day range 9.80
7.47 52-week range 14.65
- YTD
- +12.96%
- 1 year
- -30.73%
- Open
- 8.87
- Prev close
- 8.99
- Mkt cap
- 957.75M
- Vol
- 2.44M
- Avg vol
- 1.57M
- EPS
- -1.32
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 8.28
- High
- 9.80
- Forward P/E
- -7.87
- Beta
- 0.98
- Short ratio
- 11.16
- Inst. own
- 123.41%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 12, 2026
- 50-d avg
- 12.96
- 200-d avg
- 11.13
- 1y target
- 21.64
Financial health
Altman Z-Score
21.44 Safe zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
1 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
C2 / 5 overall
- DCF 2
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 4
- P/E 1
- P/B 2
Valuation
P/E -5.6×
FY 2017 5y median -4.7× FY 2025
P/S 0.0×
FY 2017 5y median 0.0× FY 2025
P/B 1.9×
FY 2017 5y median 2.0× FY 2025
P/FCF -6.3×
FY 2017 5y median -5.5× FY 2025
EV/EBITDA -5.3×
FY 2017 5y median -4.3× FY 2025
EV/Sales 0.0×
FY 2017 5y median 0.0× FY 2025
FCF Yield -15.9%
FY 2017 5y median -18.3% FY 2025
Profitability
Gross Margin 0.0%
FY 2017 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2017 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2017 5y median 0.0% FY 2025
ROE -33.7%
FY 2017 5y median -40.1% FY 2025
ROIC -36.3%
FY 2017 5y median -38.6% FY 2025
ROA -31.5%
FY 2017 5y median -35.6% FY 2025
Growth (YoY)
Revenue 0.0%
FY 2017 FY 2025
Operating Income -0.1%
FY 2017 FY 2025
EPS (diluted) 19.7%
FY 2017 FY 2025
Free Cash Flow -0.2%
FY 2017 FY 2025
Financial Health
Current Ratio 14.1×
FY 2017 5y median 13.7× FY 2025
Quick Ratio 14.1×
FY 2017 5y median 13.7× FY 2025
Debt / Equity 0.0×
FY 2017 5y median 0.0× FY 2025
Net Debt / EBITDA 0.3×
FY 2017 5y median 0.4× FY 2025
Interest Coverage 0.0×
FY 2017 5y median 0.0× FY 2025
Dividends
Dividend Yield 0.0%
FY 2017 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2017 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31